App-Quantinova.ai

BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALS

Philippe Gabriel Steg - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Bivalirudin

REDUCED DEATH, MYOCARDIAL INFARCTION, AND EARLY STENT THROMBOSIS WITH CANGRELOR VERSUS CLOPIDOGREL ON A BACKGROUND OF BIVALIRUDIN: INSIGHTS FROM CHAMPION PHOENIX

Harvey D. White - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

ARE BIODEGRADABLE POLYMER DRUG-ELUTING STENTS THE FUTURE? A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Sainath Gaddam - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THE CLINICAL SIGNIFICANCE OF CHA2DS2-VASC SCORE FOR RISK IDENTIFICATION OF ACUTE MYOCARDIAL INFARCTION DUE TO CORONARY EMBOLISM

Tatsuhiro Shibata - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

EXPRESSION OF FUNCTIONAL TISSUE FACTOR IN ACTIVATED T-LYMPHOCYTES: A CONTRIBUTION TO THROMBOSIS?

Giovanni Cimmino - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

lonomycin

PROLONGED DUAL ANTIPLATELET THERAPY FOLLOWING DRUG-ELUTING STENT IMPLANTATION: MORE BLEEDING AND NO REDUCTION IN ISCHEMIC EVENTS- A META-ANALYSIS OF CLINICAL TRIALS

Georges El-Hayek - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

IMPACT OF P2Y12 INHIBITOR CHOICE ON 30-DAY OUTCOMES AFTER PRIMARY PCI: AN ANALYSIS FROM THE EUROMAX TRIAL

Kurt Huber - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

THE EFFICACY, SAFETY, AND NET CLINICAL BENEFIT OF CANGRELOR IN WOMEN UNDERGOING ELECTIVE OR URGENT PCI: INSIGHTS FROM THE CHAMPION-PHOENIX TRIAL

Michelle L. -Donoghue - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

OPTIMIZING CROSSOVER FROM TICAGRELOR TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME: THE CAPITAL OPTI-CROSS RANDOMIZED TRIAL

Ali Pourdjabbar - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

SHORT DURATION VERSUS 1-YEAR DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTS IMPLANTATION: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Pedro Villablanca Spinetto - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

IMPACT OF SHORT VERSUS LONG DURATION DUAL ANTIPLATELET THERAPY ON CLINICAL OUTCOMES: A COMPREHENSIVE META-ANALYSIS OF ALL RANDOMIZED CLINICAL TRIALS

Salman Jamaluddin Bandeali - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN: DIFFERENTIAL BENEFIT ACROSS THE SPECTRUM OF PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

Mohamed Farag - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

WHAT IS THE OPTIMAL STRATEGY FOR THE TREATMENT OF IN-STENT THROMBOSIS?

Thibault Lhermusier - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

STENT THROMBOSIS IS NOT INCREASED IN CARDIAC ARREST PATIENTS UNDERGOING THERAPEUTIC HYPOTHERMIA: AN ANALYSIS OF 15,079 PROCEDURES

Neeraj Shah - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

COMPARISON OF CLINICAL OUTCOMES AFTER TRANSRADIAL AND TRANSFEMORAL INTERVENTIONS IN CONTEMPORARY ANTIPLATELET ERA: A PROPENSITY SCORE-MATCHED ANALYSIS

Jeong Cheon Choi - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

TEMPORAL TREND IN THE INCIDENCE OF STENT THROMBOSIS: IMPACT OF IMPROVED ANTIPLATELET REGIMEN AND EVOLVING CORONARY STENT TECHNOLOGY

Pranav Kansara - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Ticagrelor

PLATELET FUNCTION TESTING AND HEART-TYPE FATTY ACID BINDING PROTEIN LEVELS FOR RISK STRATIFICATION IN PATIENTS WITH ACUTE CORONARY SYNDROME WHO UNDERGO PERCUTANEOUS CORONARY INTERVENTION

Ian Pearson - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

DEFINITE STENT THROMBOSIS: DOES HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL MATTER?

Pranav Kansara - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

PLATELET REACTIVITY IN OLDER PATIENTS UNDERGOING INVASIVE MANAGEMENT OF NON-ST ELEVATION ACUTE CORONARY SYNDROME

Jonathan Adam Batty - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Adenosine

LONG-TERM OUTCOMES OF THROMBUS ASPIRATION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Ji-Young Yoon - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts